Ellen Goldberg
Director/Board Member presso CASTLE BIOSCIENCES, INC.
Patrimonio netto: 210 536 $ in data 31/03/2024
Profilo
Ellen Goldberg is an Independent Director at Castle Biosciences, Inc. She previously worked as the Vice President-Marketing at Crescendo Bioscience LLC from 2009 to 2011.
Ms. Goldberg holds a graduate degree and an MBA from Stanford University.
She also has an undergraduate degree from Yale University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CASTLE BIOSCIENCES, INC.
0.03% | 14/07/2023 | 9 505 ( 0.03% ) | 210 536 $ | 31/03/2024 |
Posizioni attive di Ellen Goldberg
| Società | Posizione | Inizio |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Director/Board Member | 16/07/2021 |
Precedenti posizioni note di Ellen Goldberg
| Società | Posizione | Fine |
|---|---|---|
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Sales & Marketing | 01/01/2011 |
Formazione di Ellen Goldberg
| Stanford University | Graduate Degree |
| Yale University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CASTLE BIOSCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Commercial Services |
- Borsa valori
- Insiders
- Ellen Goldberg
